PURE Bioscience, Inc. (PURE) Net margin 2017–2026
PURE Bioscience, Inc. (PURE) net profit margin by fiscal year — reported net income divided by reported revenue.
-107.1%FY2026 · since FY2017: -342.1% → -107.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -107.1% | +1.8 pp |
| FY2025 | -108.9% | +61.7 pp |
| FY2024 | -170.7% | +40.4 pp |
| FY2023 | -211.0% | -22.6 pp |
| FY2022 | -188.4% | -129.3 pp |
| FY2021 | -59.1% | -59.1 pp |
| FY2020 | 0.1% | +343.4 pp |
| FY2019 | -343.3% | +76.2 pp |
| FY2018 | -419.5% | -77.5 pp |
| FY2017 | -342.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PURE financial trends
PURE RevenuePURE Net incomePURE Gross profitPURE Gross marginPURE Operating incomePURE Operating marginPURE Operating cash flowPURE Free cash flowPURE Capital expendituresPURE Return on equityPURE Stock buybacksPURE Dividends paidPURE Total assetsPURE Total liabilitiesPURE Shareholders’ equityPURE overview →